Novel C-17-heteroaryl steroidal CYP17 inhibitors/antiandrogens: synthesis, in vitro biological activities, pharmacokinetics and antitumor activity

Details for Australian Patent Application No. 2006218711 (hide)

Owner University of Maryland, Baltimore

Inventors Njar, Vincent; Brodie, Angela

Agent Cullens

Pub. Number AU-B-2006218711

PCT Pub. Number WO2006/093993

Priority 60/657,390 02.03.05 US

Filing date 2 March 2006

Wipo publication date 8 September 2006

Acceptance publication date 11 November 2010

International Classifications

C07J 43/00 (2006.01) Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta[a]hydrophenanthrene skeleton

A61K 31/58 (2006.01) - containing heterocyclic rings, e.g. aldosterone, danazol, stanozolol, pancuronium, digitogenin

Event Publications

4 October 2007 PCT application entered the National Phase

  PCT publication WO2006/093993 Priority application(s): WO2006/093993

25 October 2007 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 13 Sep 2007

25 March 2010 Alteration of Name

  The name of the applicant has been altered to University of Maryland, Baltimore

11 November 2010 Application Accepted

  Published as AU-B-2006218711

10 March 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006218713-Foldable container including horizontally hinged sidwall sections

2006218710-Mobile portal for RFID applications